Chan Heng Fai Ambrose's Form 4 filing
Impact Biomedical Inc. (IBO) · filed Apr 4, 2025
- Accession no.
- 0001641172-25-002819
- Filed
- Apr 4, 2025, 5:15 PM ET
- Trade date
- Apr 2-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.12M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chan Heng Fai AmbroseCIK 0001261725 | Director, 10% Owner |
| Alset International LtdCIK 0001660984 | 10% Owner |
| Alset Inc.CIK 0001750106 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Common stock | SSaleDisposed | −300,000 | $0.581 | −$174,300 | 553,904 | Indirect | |
| Apr 2, 2025 | Common stock | SSaleDisposed | −200,000 | $0.674 | −$134,800 | 353,904 | Indirect | |
| Apr 2, 2025 | Common stock | SSaleDisposed | −2,349 | $0.673 | −$1,580.88 | 351,555 | Indirect | |
| Apr 2, 2025 | Common stock | SSaleDisposed | −382,427 | $0.583 | −$222,954.94 | 351,631 | Indirect | |
| Apr 3, 2025 | Common stock | SSaleDisposed | −351,631 | $0.579 | −$203,594.35 | 0 | Indirect | |
| Apr 3, 2025 | Common stock | SSaleDisposed | −273,286 | $0.779 | −$212,889.79 | 180,000 | Indirect | |
| Apr 4, 2025 | Common stock | SSaleDisposed | −180,000 | $0.96 | −$172,800 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.